Cardiac Troponin-T Release After Sport and Differences by Age, Sex, Training Type, Volume, and Intensity: A Critical Review.


Journal

Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine
ISSN: 1536-3724
Titre abrégé: Clin J Sport Med
Pays: United States
ID NLM: 9103300

Informations de publication

Date de publication:
01 05 2022
Historique:
received: 22 07 2020
accepted: 28 03 2021
pubmed: 20 5 2021
medline: 28 4 2022
entrez: 19 5 2021
Statut: ppublish

Résumé

Postexercise release of cardiac troponin (cTn) is a well-known phenomenon, although the influence of various confounders remains unclear. The aim of this critical review was to analyze the postexercise release of cTn according to age, sex, different types of sport, exercise intensity and duration, and training level. A literature search was performed within the National Library of Medicine using the following keywords: cTn, peak, release, and exercise. The search was further refined by adding the keywords athletes, children/adolescents, and sport. For final analysis, 52 studies were included: 43 adult studies, 4 pediatric studies, and 5 with a mixed population of adults and children. Several studies have investigated the kinetics of cTn response after exercise with different biomarkers. The current evidence suggests that sport intensity and duration have significant effects on postexercise cTn elevation, whereas the influence of the type of sport, age, and sex have been not completely defined yet. Most data were obtained during endurance races, whereas evidence is limited (or almost absent), particularly for mixed sports. Data on young adults and professional athletes are limited. Finally, studies on women are extremely limited, and those for non-White are absent. Postexercise release of cTn can be observed both in young and master athletes and usually represents a physiological phenomenon; however, more rarely, it may unmask a subclinical cardiac disease. The influence of different confounders (age, sex, sport type/intensity/duration, and training level) should be better clarified to establish individualized ranges of normality for postexercise cTn elevation.

Sections du résumé

BACKGROUND
Postexercise release of cardiac troponin (cTn) is a well-known phenomenon, although the influence of various confounders remains unclear. The aim of this critical review was to analyze the postexercise release of cTn according to age, sex, different types of sport, exercise intensity and duration, and training level.
DATA SOURCES
A literature search was performed within the National Library of Medicine using the following keywords: cTn, peak, release, and exercise. The search was further refined by adding the keywords athletes, children/adolescents, and sport.
MAIN RESULTS
For final analysis, 52 studies were included: 43 adult studies, 4 pediatric studies, and 5 with a mixed population of adults and children. Several studies have investigated the kinetics of cTn response after exercise with different biomarkers. The current evidence suggests that sport intensity and duration have significant effects on postexercise cTn elevation, whereas the influence of the type of sport, age, and sex have been not completely defined yet. Most data were obtained during endurance races, whereas evidence is limited (or almost absent), particularly for mixed sports. Data on young adults and professional athletes are limited. Finally, studies on women are extremely limited, and those for non-White are absent.
CONCLUSIONS
Postexercise release of cTn can be observed both in young and master athletes and usually represents a physiological phenomenon; however, more rarely, it may unmask a subclinical cardiac disease. The influence of different confounders (age, sex, sport type/intensity/duration, and training level) should be better clarified to establish individualized ranges of normality for postexercise cTn elevation.

Identifiants

pubmed: 34009785
doi: 10.1097/JSM.0000000000000940
pii: 00042752-202205000-00018
doi:

Substances chimiques

Biomarkers 0
Troponin T 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e230-e242

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest.

Références

Cirer-Sastre R, Legaz-Arrese A, Corbi F, et al. Cardiac biomarker release after exercise in healthy children and adolescents: a systematic review and meta-analysis. Pediatr Exerc Sci. 2019;31:28–36.
Baker P, Leckie T, Harrington D, et al. Exercise-I nduced cardiac troponin elevation: an update on the evidence, mechanism and implications. Int J Cardiol Heart Vasc. 2019;22:181–186.
Vilela EM, Bastos JC, Rodrigues RP, et al. High-sensitivity troponin after running—a systematic review. Neth J Med. 2014;72:5–9.
Shave R, George KP, Atkinson G, et al. Exercise-induced cardiac troponin T release: a meta-analysis. Med Sci Sports Exerc. 2007;39:2099–2106.
Donaldson JA, Wiles JD, Coleman DA, et al. Left ventricular function and cardiac biomarker release—the influence of exercise intensity, duration and mode: a systematic review and meta-analysis. Sports Med. 2019;49:1275–1289.
Masri W, Le Guillou E, Hamdi E, et al. Troponin elevation in other conditions than acute coronary syndromes. Ann Biol Clin (Paris). 2017;75:411–441.
Gresslien T, Agewall S. Troponin and exercise. Int J Cardiol. 2016;221:609–621.
Legaz-Arrese A, Carranza-García LE, Navarro-Orocio R, et al. Cardiac biomarker release after endurance exercise in male and female adults and adolescents. J Pediatr. 2017;191:96–102.
Cirer-Sastre R, Legaz-Arrese A, Corbi F, et al. Cardiac troponin T release after football 7 in healthy children and adults. Int J Environ Res Public Health. 2020;17:956.
Christou GA, Pagourelias ED, Anifanti MA, et al. Exploring the determinants of the cardiac changes after ultra-long duration exercise: the echocardiographic Spartathlon study. Eur J Prev Cardiol. 2020;27:1467–1477.
Skalenius M, Mattsson CM, Dahlberg P, et al. Performance and cardiac evaluation before and after a 3-week training camp for 400-meter sprinters - an observational, non-randomized study. PLoS One. 2019;14:e0217856.
Shave RE, Dawson E, Whyte G, et al. Evidence of exercise-induced cardiac dysfunction and elevated cTnT in separate cohorts competing in an ultra-endurance mountain marathon race. Int J Sports Med. 2002;23:489–494.
Richardson AJ, Leckie T, Watkins ER, et al. Post marathon cardiac troponin T is associated with relative exercise intensity. J Sci Med Sport. 2018;21:880–884.
Nie J, Zhang H, Kong Z, et al. The impact of exercise modality and menstrual cycle phase on circulating cardiac troponin T. J Sci Med Sport. 2020;23:309–314.
Legaz-Arrese A, López-Laval I, George K, et al. Individual variability of high-sensitivity cardiac troponin levels after aerobic exercise is not mediated by exercise mode. Biomarkers. 2015;20:219–224.
López-Laval I, Legaz-Arrese A, George K, et al. Cardiac troponin I release after a basketball match in elite, amateur and junior players. Clin Chem Lab Med. 2016;54:333–338.
Legaz-Arrese A, López-Laval I, George K, et al. Impact of an endurance training program on exercise-induced cardiac biomarker release. Am J Physiol Heart Circ Physiol. 2015;308:H913–H920.
Saravia SG, Knebel F, Schroeckh S, et al. Cardiac troponin T release and inflammation demonstrated in marathon runners. Clin Lab. 2010;56:51–58.
Baker P, Davies SL, Larkin J, et al. Changes to the cardiac biomarkers of non-elite athletes completing the 2009 London Marathon. Emerg Med J. 2013;31:374–379.
Scherr J, Braun S, Schuster T, et al. 72-h kinetics of high-sensitive troponin T and inflammatory markers after marathon. Med Sci Sports Exerc. 2011;43:1819–1827.
Legaz-Arrese A, George K, Carranza-García LE, et al. The impact of exercise intensity on the release of cardiac biomarkers in marathon runners. Eur J Appl Physiol. 2011;111:2961–2967.
Serrano-Ostáriz E, Terreros-Blanco JL, Legaz-Arrese A, et al. The impact of exercise duration and intensity on the release of cardiac biomarkers. Scand J Med Sci Sports. 2011;21:244–249.
Fortescue EB, Shin AY, Greenes DS, et al. Cardiac troponin increases among runners in the Boston Marathon. Ann Emerg Med. 2007;49:137– 43.
Tulloh L, Robinson D, Patel A, et al. Raised troponin T and echocardiographic abnormalities after prolonged strenuous exercise—the Australian Ironman Triathlon. Br J Sports Med. 2006;40:605–609.
Tian Y, Nie J, Huang C, et al. The kinetics of highly sensitive cardiac troponin T release after prolonged treadmill exercise in adolescent and adult athletes. J Appl Physiol. 2012;113:418–425.
Roca E, Nescolarde L, Lupón J, et al. The dynamics of cardiovascular biomarkers in non-elite Marathon runners. J Cardiovasc Transl Res. 2017;2:206–208.
Frassl W, Kowoll R, Katz N, et al. Cardiac markers (BNP, NT-pro-BNP, Troponin I, Troponin T) in female amateur runners before and up until three days after a marathon. Clin Lab. 2008;3:81–87.
Neumayr G, Gaenze H, Pfister R, et al. Plasma levels of cardiac troponin I after prolonged strenuous endurance exercise. Am J Cardiol. 2001;87:369–371.
Herrmann H, Scharhag J, Urhausen A, et al. Postrace kinetics of cardiac troponin T and I and N-terminal pro-brain natriuretic peptide in marathon runners. Clin Chem. 2003;49:831–834.
La Gerche A, Connelly KA, Mooney DJ, et al. Biochemical and functional abnormalities of left and right ventricular function after ultraendurance exercise biochemical and functional abnormalities of left and right ventricular function after ultra-endurance exercise. Heart. 2008;94:860–866.
Peretti A, Mauri L, Masarin A, et al. Cardiac biomarkers release in preadolescent athletes after an high intensity exercise. High Blood Press Cardiovasc Prev. 2018;25:89–96.
Mingels A, Jacobs L, Michielsen E, et al. Reference population and marathon runner era assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem. 2009;55:101–108.
Neilan TG, Januzzi JL, Lee-Lewandrowski E, et al. Myocardial injury and ventricular dysfunction related to training levels among non-elite participants in the Boston marathon. Circulation. 2006;114:2325–2333.
George K, Shave R, Oxborough D, et al. Left ventricular wall segment motion after ultra-endurance exercise in humans assessed by myocardial speckle tracking. Eur J Echocardiogr. 2009;10:238–243.
Legaz-Arrese A, López-Laval I, George K, et al. Individual variability in cardiac biomarker release after 30 min of high-intensity rowing in elite and amateur athletes. Appl Physiol Nutr Metab. 2015;40:951–958.
Cirer-Sastre R, Legaz-Arrese A, Corbi F, et al. Effect of training load on post-exercise cardiac troponin T elevations in young soccer players. Int J Environ Res Public Health. 2019:2;16.
Fu F, Nie J, Tong TK. Serum cadiac troponin T in adolescent runners: effect of exercise intensity and duration. Int J Sports Med. 2009;30:168–172.
Aagaard P, Sahlén A, Bergfeldt L, et al. Heart rate and its variability in response to running associations with troponin. Med Sci Sports Exerc. 2014;46:1624–1630.
Eijsvogels T, George K, Shave R, et al. Effect of prolonged walking on cardiac troponin levels. Am J Cardiol. 2010;105:267–272.
Jassal DS, Moffat D, Krahn J, et al. Cardiac injury markers in non-elitemarathon runners. Int J Sports Med. 2009;30:75–79.
Shave R, Baggish A, George K, et al. Exercise induced cardiac troponin elevation: evidence, mechanisms, and implications. J Am Coll Cardiol. 2010;56:169–176.
Skadberg Ø, Kleiven Ø, Bjørkavoll-Bergseth M, et al. Highly increased Troponin I levels following high-intensity endurance cycling may detect subclinical coronary artery disease in presumably healthy leisure sport cyclists: the North Sea Race Endurance Exercise Study (NEEDED) 2013. Eur J Prev Cardiol. 2017;24:885–894.
Hubble KM, Fatovich DM, Grasko JM, et al. Cardiac troponin increases among marathon runners in the Perth Marathon: the Troponin in Marathons (TRIM) study. Med J Aust. 2009;190:91–93.
Martínez-Navarro I, Sánchez-Gómez JM, Collado-Boira EJ, et al. Cardiac damage biomarkers and heart rate variability following a 118-km mountain race: relationship with performance and recovery. J Sports Sci Med. 2019;18:615–622.
Danielsson T, Carlsson J, Schreyer H, et al. Blood biomarkers in male and female participants after an Ironman-distance triathlon. PLoS One. 2017;12:e0179324.
Cleave P, Boswell TD, Speedy DB, et al. Plasma cardiac troponin concentrations after extreme exercise. Clin Chem. 2001;47:608–610.
Scharhag J, Herrmann M, Urhausen A, et al. Independent elevations of N-terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise. Am Heart J. 2005;150:1128.
Sahlén A, Shahgaldi K, Aminoff A, et al. Effects of prolonged exercise on left ventricular mechanical synchrony in long-distance runners: importance of previous exposure to endurance races. J Am Soc Echocardiogr. 2010;23:977–984.
Sahlén A, Winter R, Lind B, et al. Magnitude, reproducibility, and association with baseline cardiac function of cardiac biomarker release in long-distance runners aged > or =55 years. Am J Cardiol. 2008;102:218–222.
Siegel AJ, Januzzi J, Sluss P, et al. Cardiac biomarkers, electrolytes, and other analytes in collapsed marathon runners: implications for the evaluation of runners following competition. Am J Clin Pathol. 2008;129:948–951.
Siegel AJ, Sholar M, Yang J, et al. Elevated serum cardiacmarkers in asymptomaticmarathon runners after competition: is themyocardium stunned? Cardiology. 1997;88:487–491.
Ma G, Liu Y, Liu K. Influence of repeated bouts of table tennis training on cardiac biomarkers in children. Pediatr Cardiol. 2014;35:711–718.
Scott JM, Esch BT, Shave R, et al. Cardiovascular consequences of completing a 160-km ultramarathon. Med Sci Sports Exerc. 2009;41:26–34.
Leers MP, Schepers R, Baumgarten R. Effects of a long distance run on cardiac markers in healthy athletes. Clin Chem Lab Med. 2006;44:999–1003.
Ashley EA, Kardos A, Jack ES, et al. Angiotensin-converting enzyme genotype predicts cardiac and autonomic responses to prolonged exercise. J Am Coll Cardiol. 2006;48:523–531.
Denvir MA, Galloway PJ, Meighan AS, et al. Changes in skeletal and cardiac muscle enzymes during the scottish coast to coast triathlon. Scott Med J. 1999;44:49–51.
Dalla Vecchia L, Traversi E, Porta A, et al. Onsite assessment of cardiacfunction and neural regulation in amateur half marathon runners. Open Heart. 2014;1:e000005.
Vidotto C, Tschan H, Atamaniuk J, et al. Responses of N-terminal pro-brain natriuretic peptide (NT-proBNP) and cardiac troponin I (cTnI) to competitive endurance exercise in recreational athletes. Int J Sports Med. 2005;26:645–650.
Romagnoli M, Alis R, Aloe R, et al. Influence of training and a maximal exercise test in analytical variability of muscular, hepatic, and cardiovascular biochemical variables. Scand J Clin Lab Invest. 2014;74:192–198.
Klinkenberg LJ, Res PT, van Loon LJ, et al. Strong link between basal and exercise-induced cardiac troponin T levels: do both reflect risk? Int J Cardiol. 2012;158:129–131.
Koller A, Summer P, Moser H. Regular exercise and subclinical myocardial injury during prolonged aerobic exercise. JAMA. 1999;282:1816.
Koller A, Sumann G, Griesmacher A, et al. Cardiac troponins after a downhill marathon. Int J Cardiol. 2008;129:449–452.
Carranza-Garcia LE, George K, Serrano-Ostariz E, et al. Cardiac biomarker response to intermittent exercise bouts. Int J Sports Med. 2011;32:327–331.
Wedin JO, Henriksson AE. Postgame elevation of cardiac markers among elite floorball players. Scand J Med Sci Sports. 2015;25:495–500.
Bonetti A, Tirelli F, Albertini R, et al. Serum cardiac troponin T after repeated endurance exercise events. Int J Sports Med. 1996;17:259–262.
Sribhen K, Piyophirapong S, Wannasilp N. Cardiac troponin T concentrations in healthy adolescents. Clin Chim Acta. 2010;411:1542–1543.
Giannoni A, Giovannini S, Clerico A. Measurement of circulating concentrations of cardiac troponin I and T in healthy subjects: a tool for monitoring myocardial tissue renewal? Clin Chem Lab Med. 2009;47:1167–1177.
Clerico A, Ripoli A, Zaninotto M, et al. Head-to-head comparison of plasma cTnI concentration values measured with three high-sensitivity methods in a large Italian population of healthy volunteers and patients admitted to emergency department with acute coronary syndrome: a multi-center study. Clin Chim Acta. 2019;496:25–34.
Clerico A, Zaninotto M, Padoan A, et al. Evaluation of analytical performance of immunoassay methods for cTnI and cTnT: from theory to practice. Adv Clin Chem. 2019;93:239–262.
Eijsvogels TM, Fernandez AB, Thompson PD. Are there deleterious cardiac effects of acute and chronic endurance exercise? Physiol Rev. 2016;96:99–125.
Aakre KM, Omland T. Physical activity, exercise, and cardiac troponins: clinical implications. Prog Cardiovasc Dis. 2019:62:108–115.
Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction. J Am Coll Cardiol. 2018;72:2231–2264.
Roffi M, Patrono C, Collet JP, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:267–315.
Mazzeschi C, Piana N, Capezzali D, et al. The impact of strenuous group physical activity on mood states, personal views, body composition, and markers of myocardial damage in overweight/obese adults: the “step-by-step Italy's coast to coast” trek. Biomed Res Int. 2014;2014:854129.
Planer D, Leibowitz D, Hadid A, et al. The effect of prolonged physical activity performed during extreme caloric deprivation on cardiac function. PLoS One. 2012;7:e31266.
Clerico A, Giannoni A, Prontera C, et al. High-sensitivity troponin: a new tool for pathophysiological investigation and clinical practice. Adv Clin Chem. 2009;49:1–30.
Hickman PE, Potter JM, Aroney C, et al. Cardiac troponin may be released by ischemia alone, without necrosis. Clin Chim Acta. 2010;411:318–323.
Marjot J, Kaier TE, Martin ED, et al. Quantifying the release of biomarkers of myocardial necrosis from cardiac myocytes and intact myocardium. Clin Chem. 2017;63:990–996.
Mair J, Lindahl B, Hammarsten O, et al. How is cardiac troponin released from injured myocardium? Eur Heart J Acute Cardiovasc Care. 2018;7:553–560.
Clerico A, Zaninotto M, Passino C, et al. Evidence on clinical relevance of cardiovascular risk evaluation in the general population using cardio-specific biomarkers. Chem Lab Med. 2020;59:79–90.
Pelliccia A, Sharma S, Gati S, et al.; ESC Scientific Document Group. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. 2021;42:17–96.
Caselli C, Cangemi G, Masotti S, et al. Plasma cardiac troponin I concentrations in healthy neonates, children and adolescents measured with a highly sensitive immunoassay method: highly sensitive troponin I in pediatric age. Clin Chim Acta. 2016;458:68–71.
Caselli C, Ragusa R, Prontera C, et al. Distribution of circulating cardiac biomarkers in healthy children: from birth through adulthood. Biomark Med. 2016;10:357–365.
Jehlicka P, Huml M, Rajdl D, et al. How to interpret elevated plasmatic level of high-sensitive troponin T in newborns and infants? Physiol Res. 2018;67:191–195.
Mondal T, Ryan PM, Gupta K, et al. Cord-blood high-sensitivity troponin-I reference interval and association with early neonatal outcomes. Am J Perinatol. 2021. doi: 10.1055/s-0041-1722944.
doi: 10.1055/s-0041-1722944

Auteurs

Massimiliano Cantinotti (M)

Pediatric Cardiology Unit, Fondazione CNR-Regione Toscana G. Monasterio, Massa, Italy.
Pediatric Cardiology Unit, Institute of Clinical Physiology (IFC) National Research Institute (CNR), Pisa, Italy.

Aldo Clerico (A)

Pediatric Cardiology Unit, Fondazione CNR-Regione Toscana G. Monasterio, Massa, Italy.

Raffaele Giordano (R)

Department Advanced Biomedica Sciences, University of Naples Federico II, Naples, Italy.

Nadia Assanta (N)

Pediatric Cardiology Unit, Fondazione CNR-Regione Toscana G. Monasterio, Massa, Italy.

Eliana Franchi (E)

Pediatric Cardiology Unit, Fondazione CNR-Regione Toscana G. Monasterio, Massa, Italy.

Martin Koestenberger (M)

Department Advanced Biomedica Sciences, University of Naples Federico II, Naples, Italy.
Division of Pediatric Cardiology, Department of Pediatrics, Medical University Graz, Austria; and.

Pietro Marchese (P)

Pediatric Cardiology Unit, Fondazione CNR-Regione Toscana G. Monasterio, Massa, Italy.

Simona Storti (S)

Pediatric Cardiology Unit, Fondazione CNR-Regione Toscana G. Monasterio, Massa, Italy.

Flavio D'Ascenzi (F)

Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Italy .

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH